Metropolis Healthcare opens MedEngage Scholarship programme
The last date to apply for this program is 18th January 2022
The last date to apply for this program is 18th January 2022
Four-year research collaboration combines Pfizer’s deep experience in global drug development, including programs utilizing messenger RNA (mRNA), lipid nanoparticles (LNP), and gene therapy, with Beam’s leadership in base editing and mRNA/LNP delivery technologies
He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management
The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space
Immatics to receive upfront payment of US $ 150 million and additional milestone payments of up to US $ 770 million plus tiered double-digit royalties on net product sales
Both companies will combine their expertise to channel real-world evidence toward ground-breaking new treatments in rare diseases
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
Molbio Diagnostics has been the pioneer in providing access to molecular testing through its Truenat Real Time PCR platform. Sriram Natarajan, Director & CEO, of the company shares his experiences on the journey so far in an interview with Thomas C Thottathil
The initiative will engage adolescents and youth of India in decisions about their reproductive health
Carestream equipment is highly recommended for its imaging quality
Subscribe To Our Newsletter & Stay Updated